内部人交易雷达

美国 · SEC Form 4 · 快照日期: 2026-10-18 · 构建时间: 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Viatris Inc

VTRS · Nasdaq · CIK 0001792044 · Healthcare · Drug Manufacturers—Specialty & Generic

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

5 同一窗口内观察到的 Form 4 交易行
1 sales · 4 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2025-11-03 · SIMMONS DAVID S · $2.2K

为什么没有活跃信号?

买入活动无
近期买入无
近期卖出较低
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数?

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。

卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。

AprMayJunJulAugSepOct
Enrietti AndrewSee Remarks
○○
Campbell PaulSee Remarks
▼
● 买入▼ 卖出○ 其他

—

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后,这些模块才会启用。

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-11-03 · SIMMONS DAVID S.

近期 Form 4 活动

1买入
2卖出
96其他 Form 4 交易行
27SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出1 sale line(s) · 仅供背景
其他4 exercise / withholding / award / gift / other lines
10b5-1/计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。

空头股数
42,038,581
上期报告
40,790,228
日均成交量
10,090,838
回补天数
4.2

FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2025-11-03SIMMONS DAVID S买入 (P)Common Stock213USD 10.43USD 2,222SEC 申报 ↗
2025-08-27SIMMONS DAVID S买入 (P)Common Stock286USD 10.42USD 2,980SEC 申报 ↗
2025-08-12Smith Scott Andrew买入 (P)Common Stock22,000USD 9.99USD 219,780SEC 申报 ↗
2025-05-12Smith Scott Andrew买入 (P)Common Stock60,000USD 8.94USD 536,400SEC 申报 ↗
2023-10-26KORMAN HARRY买入 (P)Common Stock19USD 9.01USD 171SEC 申报 ↗
2022-03-16KORMAN HARRY买入 (P)Common Stock239USD 10.42USD 2,488SEC 申报 ↗
2022-03-15GOETTLER MICHAEL买入 (P)Common Stock50,352USD 9.87USD 496,974SEC 申报 ↗
2022-03-15CORNWELL W DON买入 (P)Common Stock2,700USD 9.90USD 26,730SEC 申报 ↗
2022-03-04KORMAN HARRY买入 (P)Common Stock1,150USD 10.08USD 11,592SEC 申报 ↗
2021-12-16KORMAN HARRY买入 (P)Common Stock176USD 12.84USD 2,262SEC 申报 ↗
2021-09-16KORMAN HARRY买入 (P)Common Stock162USD 13.81USD 2,243SEC 申报 ↗
2021-06-16KORMAN HARRY买入 (P)Common Stock145USD 15.39USD 2,227SEC 申报 ↗
2021-05-21CORNWELL W DON买入 (P)Common Stock500USD 15.45USD 7,725SEC 申报 ↗
2021-05-19CORNWELL W DON买入 (P)Common Stock1,500USD 15.79USD 23,685SEC 申报 ↗
2021-03-09KORMAN HARRY买入 (P)Common Stock349USD 13.94USD 4,865SEC 申报 ↗

Form 4 申报证据

99 transaction lines in the latest 365-day window; 657 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-08-15Enrietti Andrew期权行权/转换 (M)Common Stock26,133USD 0.00USD 0SEC 申报 ↗
2026-08-15Enrietti Andrew代扣税 (F)Common Stock11,366USD 16.23USD 184,470SEC 申报 ↗
2026-06-25Campbell Paul卖出 (S)Common Stock50,076USD 16.17USD 809,729SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-08-15Enrietti Andrew期权行权/转换 (M)Common Stock26,133USD 0.00USD 0SEC 申报 ↗
2026-08-15Enrietti Andrew代扣税 (F)Common Stock11,366USD 16.23USD 184,470SEC 申报 ↗
2026-06-25Campbell Paul卖出 (S)Common Stock50,076USD 16.17USD 809,729SEC 申报 ↗
2026-04-15Le Goff Corinne期权行权/转换 (M)Common Stock42,988USD 0.00USD 0SEC 申报 ↗
2026-04-15Le Goff Corinne代扣税 (F)Common Stock19,067USD 13.86USD 264,269SEC 申报 ↗
2026-03-23Campbell Paul卖出 (S)Common Stock21,350USD 13.28USD 283,528SEC 申报 ↗
2026-03-06Vivaldi Coelho Rogerio期权行权/转换 (M)Common Stock24,835USD 0.00USD 0SEC 申报 ↗
2026-03-06Smith Scott Andrew期权行权/转换 (M)Common Stock130,701USD 0.00USD 0SEC 申报 ↗
2026-03-06Smith Scott Andrew代扣税 (F)Common Stock51,432USD 14.16USD 728,277SEC 申报 ↗
2026-03-06SIMMONS DAVID S期权行权/转换 (M)Common Stock23,344USD 0.00USD 0SEC 申报 ↗
2026-03-06SEVERINO MICHAEL期权行权/转换 (M)Common Stock26,031USD 0.00USD 0SEC 申报 ↗
2026-03-06PARRISH MARK W期权行权/转换 (M)Common Stock24,835USD 0.00USD 0SEC 申报 ↗
2026-03-06Mistras Theodora期权行权/转换 (M)Common Stock43,782USD 0.00USD 0SEC 申报 ↗
2026-03-06Mistras Theodora代扣税 (F)Common Stock24,213USD 14.16USD 342,856SEC 申报 ↗
2026-03-06MARK RICHARD A期权行权/转换 (M)Common Stock24,835USD 0.00USD 0SEC 申报 ↗
2026-03-06Lyons Dillon JoEllen期权行权/转换 (M)Common Stock24,835USD 0.00USD 0SEC 申报 ↗
2026-03-06Le Goff Corinne期权行权/转换 (M)Common Stock46,358USD 0.00USD 0SEC 申报 ↗
2026-03-06Le Goff Corinne代扣税 (F)Common Stock20,561USD 14.16USD 291,144SEC 申报 ↗
2026-03-06KILTS JAMES M期权行权/转换 (M)Common Stock24,835USD 0.00USD 0SEC 申报 ↗
2026-03-06HIGGINS MELINA E期权行权/转换 (M)Common Stock24,835USD 0.00USD 0SEC 申报 ↗
2026-03-06Groothuis Leo Frans期权行权/转换 (M)Common Stock24,835USD 0.00USD 0SEC 申报 ↗
2026-03-06Groothuis Leo Frans代扣税 (F)Common Stock1,305USD 14.16USD 18,479SEC 申报 ↗
2026-03-06FINNEY ELISHA W期权行权/转换 (M)Common Stock24,835USD 0.00USD 0SEC 申报 ↗
2026-03-06Enrietti AndrewX (X)Common Stock20,121USD 0.00USD 0SEC 申报 ↗
2026-03-06Enrietti Andrew代扣税 (F)Common Stock8,752USD 14.16USD 123,928SEC 申报 ↗
2026-03-06DAMELIO FRANK A期权行权/转换 (M)Common Stock26,031USD 0.00USD 0SEC 申报 ↗
2026-03-06Campbell Paul期权行权/转换 (M)Common Stock28,974USD 0.00USD 0SEC 申报 ↗
2026-03-06Campbell Paul代扣税 (F)Common Stock12,689USD 14.16USD 179,676SEC 申报 ↗
2026-03-06CORNWELL W DON期权行权/转换 (M)Common Stock24,835USD 0.00USD 0SEC 申报 ↗
2026-03-04Smith Scott Andrew期权行权/转换 (M)Common Stock101,217USD 0.00USD 0SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码VTRS
CIK0001792044
行业Healthcare
细分行业Drug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史657 transaction lines from 2020-11-13 to 2026-08-15
20 P purchase lines · 32 S sale lines · 605 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.